VAGIFEM Side Effects

7020150-3 | Eczema, Erysipelas, Oedema Peripheral, Pruritus, Rash
on Sep 22, 2010 Female patient from DENMARK , 63 years of age, weighting 143.3 lb, was diagnosed with vulvovaginal dryness and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), erysipelas, oedema peripheral, pruritus, rash (What is rash?). Vagifem dosage: .

7004847-7 | Breast Cancer, Lymph Node Cancer Metastatic, Lymphoedema
Patient was taking Vagifem (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), lymph node cancer metastatic, lymphoedema on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, . Vagifem dosage: 25 Mcg. During the same period patient was treated with ESTRACE (Unk) (View Estrace Review and Estrace Label ), PROVERA (Unk) (View Provera Review and Provera Label ), PREMPRO (0.625/2.5 Mg) (View Prempro Review and Prempro Label ).

6999075-5 | Vulvovaginitis
Adverse event was reported on Sep 09, 2010 by a Female patient taking Vagifem (View Usage) (Dosage: 2 To 3 Tab, Qw) was diagnosed with senile genital atrophy and. Location: DENMARK , 67 years of age, After Vagifem was administered, patient had the following side effects: vulvovaginitis.

6924866-6 | Atrial Fibrillation, Blood Pressure Increased, Heart Rate Increased
on Aug 06, 2010 Female patient from UNITED STATES , 65 years of age, was diagnosed with menopausal symptoms and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood pressure increased, heart rate increased. Vagifem dosage: Once A Week. Patient was hospitalized.


6910180-1 | Sarcoidosis
on Jul 30, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with vulvovaginal dryness, hypothyroidism and was treated with Vagifem (View Usage). Patient had the following side effects: sarcoidosis. Vagifem dosage: 25 Ug, Biw. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6899942-7 | Breast Cancer, Hot Flush, Withdrawal Syndrome
Patient was taking Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: breast cancer (What is breast cancer?), hot flush, withdrawal syndrome on Jul 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, was diagnosed with atrophic vulvovaginitis, seasonal allergy and. Vagifem dosage: 1 Df, Unk. During the same period patient was treated with BECONASE (View Beconase Review and Beconase Label ), LORATADINE (10 Mg, Unk) (View Loratadine Review and Loratadine Label ).

6879673-X | Endometrial Cancer Stage I
Adverse event was reported on Jun 26, 2007 by a Female patient taking Vagifem (View Usage) (Dosage: ) was diagnosed with atrophic vulvovaginitis, hypertension, hypercholesterolaemia, sinusitis (What is sinusitis?), flatulence, constipation (What is constipation?) and. Location: UNITED STATES , weighting 143.5 lb, Patient experienced the following unwanted or unexpected effects: endometrial cancer stage i. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), SIMETHICON (View Simethicon Review and Simethicon Label ), HERBAL LAXATIVE (View Herbal Laxative Review and Herbal Laxative Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6878899-9 | Breast Cancer, Hot Flush
on Jul 16, 2010 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with atrophic vulvovaginitis, seasonal allergy and was treated with Vagifem (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), hot flush. Vagifem dosage: 1 Df, Unk. During the same period patient was treated with BECONASE (View Beconase Review and Beconase Label ), LORATADINE (10 Mg, Unk) (View Loratadine Review and Loratadine Label ).

6877146-1 | Endometrial Cancer
on Jul 27, 2010 Female patient from UNITED STATES , weighting 126.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: endometrial cancer. Vagifem dosage: 1 Tab Twice Weekly Vag.

6860025-3 | Vaginal Discharge, Vaginal Dysplasia
Patient was taking Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: vaginal discharge, vaginal dysplasia on Jul 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 117.0 lb, was diagnosed with vulvovaginal dryness, vitamin supplementation and. Vagifem dosage: 25 Ug, Biw. During the same period patient was treated with CALCIUM (Unk) (View Calcium Review and Calcium Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6822552-4 | Diarrhoea, Hot Flush, Malaise
Adverse event was reported on Jun 28, 2010 by a Female patient taking Vagifem (View Usage) (Dosage: 1 Tab, Qd) was diagnosed with atrophic vulvovaginitis and. Location: UNITED KINGDOM , 57 years of age, Patient had the following side effects: diarrhoea, hot flush, malaise. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6815059-1 | Vulvovaginitis
on Jun 25, 2010 Female patient from SWEDEN , 67 years of age, was diagnosed with senile genital atrophy and was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: vulvovaginitis. Vagifem dosage: 2 To 3 Tab, Qw.

6747792-4 | Chills, Diarrhoea, Headache, Hyperhidrosis, Hypotension, Syncope
on May 18, 2010 Female patient from CANADA , 47 years of age, weighting 114.6 lb, was diagnosed with atrophic vulvovaginitis and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: chills, diarrhoea, headache (What is headache?), hyperhidrosis, hypotension, syncope. Vagifem dosage: 1 Tab, Qd. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ), IRON (Unk Tab, Unk) (View Iron Review and Iron Label ).

6709212-5 | Chills, Diarrhoea, Headache, Hyperhidrosis, Hypotension, Syncope
Patient was taking Vagifem (View Usage). Patient had the following side effects: chills, diarrhoea, headache (What is headache?), hyperhidrosis, hypotension, syncope on Apr 23, 2010 from CANADA Additional patient health information: Female patient , 47 years of age, weighting 114.6 lb, was diagnosed with atrophic vulvovaginitis and. Vagifem dosage: 1 Tab, Qd. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ), IRON (Unk Tab, Unk) (View Iron Review and Iron Label ).

6676280-9 | Diarrhoea, Hot Flush, Malaise
Adverse event was reported on Mar 30, 2010 by a Female patient taking Vagifem (View Usage) (Dosage: 1 Tab, Qd) was diagnosed with atrophic vulvovaginitis and. Location: UNITED KINGDOM , 57 years of age, After Vagifem was administered, patient had the following side effects: diarrhoea, hot flush, malaise. During the same period patient was treated with CITALOPRAM (20 Mg, Qd) (View Citalopram Review and Citalopram Label ).

6674321-6 | Embolic Stroke, Heart Rate Irregular, Hypertension, Malaise
on Mar 30, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with vulvovaginal dryness, sexually active, labile hypertension, gastrooesophageal reflux disease and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: embolic stroke, heart rate irregular, hypertension, malaise. Vagifem dosage: 25 Ug, Biw. During the same period patient was treated with RAMIPRIL (50 Mg, Qd) (View Ramipril Review and Ramipril Label ), TOPROL XL (50 Mg, Qd) (View Toprol-xl Review and Toprol-xl Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ), OMEPRAZOLE (1 Tab, Qd) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6660461-4 | Eczema, Erysipelas, Oedema Peripheral, Pruritus, Rash
on Mar 23, 2010 Female patient from DENMARK , 63 years of age, weighting 143.3 lb, was diagnosed with vulvovaginal dryness and was treated with Vagifem (View Usage). Patient had the following side effects: eczema (What is eczema?), erysipelas, oedema peripheral, pruritus, rash (What is rash?). Vagifem dosage: .

6523549-4 | Deep Vein Thrombosis, Sensory Disturbance, Visual Impairment
Patient was taking Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), sensory disturbance, visual impairment on Dec 23, 2009 from DENMARK Additional patient health information: Female patient , 76 years of age, weighting 176.4 lb, was diagnosed with uterine prolapse, genital discomfort, hypothyroidism, hypertension and. Vagifem dosage: 2 Doses A Week. During the same period patient was treated with ELTROXIN (50 Mg, Qd) (View Eltroxin Review and Eltroxin Label ), DIOVAN /01319601/ (80 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ), CENTYL MITE W/POTASSIUM CHLORIDE (Unk) (View Centyl Mite W/potassium Chloride Review and Centyl Mite W/potassium Chloride Label ). Patient was hospitalized.

6504980-X | Benign Ovarian Tumour
Adverse event was reported on Dec 08, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: 1 Every 4 Days) was diagnosed with panic attack, thyroid disorder, vitamin d deficiency and. Location: UNITED STATES , weighting 136.0 lb, Patient experienced the following unwanted or unexpected effects: benign ovarian tumour. During the same period patient was treated with XANAX (2 Mg, Qd) (View Xanax Review and Xanax Label ), PAXIL (40 Mg, Qid) (View Paxil Review and Paxil Label ), REMERON (30 Mg, Qd) (View Remeron Review and Remeron Label ), METHAMIZOL (5 Mg, Qod) (View Methamizol Review and Methamizol Label ), VITAMIN A (Unk) (View Vitamin A Review and Vitamin A Label ). Patient was hospitalized.

6467749-0 | Dizziness, Hypersensitivity, Nausea
on Nov 24, 2009 Female patient from CANADA , 55 years of age, was diagnosed with vulvovaginal dryness and was treated with Vagifem (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypersensitivity, nausea (What is nausea?). Vagifem dosage: 1 Tab, Qd (one Tablet For Two Weeks Then Twice Weekly). Patient was hospitalized.

6461335-4 | Anaphylactoid Reaction
on Nov 20, 2009 Female patient from CANADA , 48 years of age, weighting 189.6 lb, was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: anaphylactoid reaction. Vagifem dosage: Unk. During the same period patient was treated with MULTI VITAMINS VITAFIT (View Multi-vitamins Vitafit Review and Multi-vitamins Vitafit Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6460895-7 | Deep Vein Thrombosis, Sensory Disturbance, Visual Impairment
Patient was taking Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), sensory disturbance, visual impairment on Nov 16, 2009 from DENMARK Additional patient health information: Female patient , 76 years of age, weighting 176.4 lb, was diagnosed with uterine prolapse, genital discomfort, hypothyroidism, hypertension and. Vagifem dosage: 2 Doses A Week. During the same period patient was treated with ELTROXIN (50 Mg, Qd) (View Eltroxin Review and Eltroxin Label ), DIOVAN /01319601/ (80 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ), CENTYL MITE W/POTASSIUM CHLORIDE (Unk) (View Centyl Mite W/potassium Chloride Review and Centyl Mite W/potassium Chloride Label ). Patient was hospitalized.

6456590-0 | Deep Vein Thrombosis, Sensory Disturbance, Visual Impairment
Adverse event was reported on Nov 16, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: 2 Doses A Week) was diagnosed with uterine prolapse, genital discomfort, hypothyroidism, hypertension and. Location: DENMARK , 76 years of age, weighting 176.4 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), sensory disturbance, visual impairment. During the same period patient was treated with ELTROXIN (50 Mg, Qd) (View Eltroxin Review and Eltroxin Label ), DIOVAN /01319601/ (80 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ), CENTYL MITE W/POTASSIUM CHLORIDE (Unk) (View Centyl Mite W/potassium Chloride Review and Centyl Mite W/potassium Chloride Label ). Patient was hospitalized.

6428195-9 | Deep Vein Thrombosis, Sensory Disturbance, Visual Impairment
on Oct 26, 2009 Female patient from DENMARK , 76 years of age, weighting 176.4 lb, was diagnosed with uterine prolapse, genital discomfort, hypothyroidism, hypertension and was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), sensory disturbance, visual impairment. Vagifem dosage: 2 Doses A Week. During the same period patient was treated with ELTROXIN (50 Mg, Qd) (View Eltroxin Review and Eltroxin Label ), DIOVAN /01319601/ (80 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ), CENTYL MITE W/POTASSIUM CHLORIDE (Unk) (View Centyl Mite W/potassium Chloride Review and Centyl Mite W/potassium Chloride Label ). Patient was hospitalized.

6428190-X | Urticaria
on Oct 28, 2009 Female patient from CROATIA (local name: Hrvatska) , 65 years of age, weighting 127.9 lb, was diagnosed with atrophic vulvovaginitis and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Vagifem dosage: 25 Ug, Qd.

6406419-1 | Dizziness, Hypersensitivity, Nausea
Patient was taking Vagifem (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypersensitivity, nausea (What is nausea?) on Oct 07, 2009 from CANADA Additional patient health information: Female patient , 55 years of age, was diagnosed with vulvovaginal dryness and. Vagifem dosage: 1 Tab, Qd (one Tablet For Two Weeks Then Twice Weekly). Patient was hospitalized.

6366339-8 | Diarrhoea
Adverse event was reported on Sep 08, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: 25 Ug, Qd) was diagnosed with atrophic vulvovaginitis and. Location: DENMARK , weighting 130.1 lb, After Vagifem was administered, patient had the following side effects: diarrhoea.

6346023-7 | Eczema, Erysipelas, Oedema Peripheral, Pruritus, Rash
on Aug 31, 2009 Female patient from DENMARK , 63 years of age, weighting 143.3 lb, was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), erysipelas, oedema peripheral, pruritus, rash (What is rash?). Vagifem dosage: .

6335292-5 | Deep Vein Thrombosis
on Aug 20, 2009 Female patient from DENMARK , 76 years of age, weighting 176.4 lb, was diagnosed with hypothyroidism, hypertension and was treated with Vagifem (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Vagifem dosage: . During the same period patient was treated with ELTROXIN (50 Mg, Qd) (View Eltroxin Review and Eltroxin Label ), DIOVAN /01319601/ (80 Mg, Qd) (View Diovan /01319601/ Review and Diovan /01319601/ Label ). Patient was hospitalized.

6335013-6 | Abdominal Pain Lower, Back Pain, Vaginal Haemorrhage
Patient was taking Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: abdominal pain lower, back pain (What is back pain?), vaginal haemorrhage on Aug 19, 2009 from CANADA Additional patient health information: Female patient , 55 years of age, weighting 368.2 lb, was diagnosed with vulvovaginal dryness, smear cervix abnormal and. Vagifem dosage: 1 Tab, Qd. Patient was hospitalized.

6312965-1 | Dry Eye, Vision Blurred
Adverse event was reported on Aug 14, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: 1 Tablet 2x/week Vag) was diagnosed with vulvovaginal dryness and. Location: UNITED STATES , 54 years of age, weighting 152.0 lb, Patient experienced the following unwanted or unexpected effects: dry eye, vision blurred.

6290915-4 | Abdominal Pain Lower, Back Pain, Vaginal Haemorrhage
on Jul 21, 2009 Female patient from CANADA , 55 years of age, weighting 368.2 lb, was diagnosed with vulvovaginal dryness, smear cervix abnormal and was treated with Vagifem (View Usage). Patient had the following side effects: abdominal pain lower, back pain (What is back pain?), vaginal haemorrhage. Vagifem dosage: 1 Tab, Qd. Patient was hospitalized.

6288294-1 | Diarrhoea
on Jul 20, 2009 Female patient from DENMARK , weighting 130.1 lb, was diagnosed with atrophic vulvovaginitis and was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: diarrhoea. Vagifem dosage: 25 Ug, Qd.

6203641-4 | Blood Pressure Increased, Chest Discomfort, Dizziness, Headache, Insomnia, Mental Impairment, Pain In Jaw, Tachycardia
Patient was taking Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, chest discomfort, dizziness (What is dizziness?), headache (What is headache?), insomnia, mental impairment, pain in jaw, tachycardia on May 22, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 116.0 lb, was diagnosed with vulvovaginal dryness and. Vagifem dosage: One Half Tab 2 X Week Vag.

6192541-4 | Hypertension
Adverse event was reported on May 06, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: ) was diagnosed with arthritis (What is arthritis?) and. Location: SWEDEN , 67 years of age, Patient had the following side effects: hypertension. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ARTROX (View Artrox Review and Artrox Label ).

6192110-6 | Breast Cancer
on May 05, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with menopause (What is menopause?), contraception, nasal congestion, stress (What is stress?), fungal infection (What is fungal infection?) and was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: breast cancer (What is breast cancer?). Vagifem dosage: 25 Ug Tablets. During the same period patient was treated with PREMPRO (.625/2.5 Mg, Qd) (View Prempro Review and Prempro Label ), FEMHRT (1 Tab, Qd) (View Femhrt Review and Femhrt Label ), ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ), ALLEGRA (View Allegra Review and Allegra Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), BUPROPION HCL ER (View Bupropion Hcl Er Review and Bupropion Hcl Er Label ).

6182749-6 | Retinal Vascular Thrombosis
on Apr 28, 2009 Female patient from DENMARK , 67 years of age, was diagnosed with vulvovaginal dryness and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vascular thrombosis. Vagifem dosage: 1 Tab, Biw.

6149839-5 | Diabetes Mellitus
Patient was taking Vagifem (View Usage). Patient had the following side effects: diabetes mellitus on Apr 02, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 158.0 lb, was diagnosed with vulvovaginal pain, hypertension, cardiac disorder, arthritis (What is arthritis?) and. Vagifem dosage: Unk, Biw. During the same period patient was treated with METOPROLOL (50 Mg, Bid) (View Metoprolol Review and Metoprolol Label ), ASPIRIN (81 Mg, Unk) (View Aspirin Review and Aspirin Label ), IBUPROFEN (600 Mg, Prn) (View Ibuprofen Review and Ibuprofen Label ).

6093264-2 | Retinal Vascular Thrombosis
Adverse event was reported on Feb 17, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: ) . Location: DENMARK , 67 years of age, After Vagifem was administered, patient had the following side effects: retinal vascular thrombosis.

6085263-1 | Breast Cancer
on Feb 11, 2009 Female patient from UNITED STATES , weighting 126.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Vagifem dosage: 25 Ug, Unk. During the same period patient was treated with PREMARIN (.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), CLIMARA (.05 Mg, Unk) (View Climara Review and Climara Label ), MEDROXYPROGESTERONE ACETATE (10 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ), ESTRING (2 Mg, Unk) (View Estring Review and Estring Label ), ESTRACE (View Estrace Review and Estrace Label ).

6075308-7 | Breast Cancer
on Feb 02, 2009 Female patient from UNITED STATES , weighting 126.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Vagifem (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Vagifem dosage: 25 Ug, Unk. During the same period patient was treated with PREMARIN (.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), CLIMARA (.05 Mg, Unk) (View Climara Review and Climara Label ), MEDROXYPROGESTERONE ACETATE (10 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ), ESTRING (2 Mg, Unk) (View Estring Review and Estring Label ), ESTRACE (View Estrace Review and Estrace Label ).

6058439-7 | Retinal Vascular Thrombosis
Patient was taking Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: retinal vascular thrombosis on Jan 19, 2009 from DENMARK Additional patient health information: Female patient , 67 years of age, . Vagifem dosage: . During the same period patient was treated with HJERTEMAGNYL /00228701/ (75 Mg, Qd) (View Hjertemagnyl /00228701/ Review and Hjertemagnyl /00228701/ Label ), SIMVASTATIN (40 Mg, Unk) (View Simvastatin Review and Simvastatin Label ).

6047934-2 | Breast Cancer
Adverse event was reported on Jan 12, 2009 by a Female patient taking Vagifem (View Usage) (Dosage: Unk, Unk) was diagnosed with menopausal symptoms, ill-defined disorder and. Location: UNITED STATES , weighting 114.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with ESTROGEN NOS (View Estrogen Nos Review and Estrogen Nos Label ), CENESTIN (.625 Mg, Unk) (View Cenestin Review and Cenestin Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), ESTRING (2 Mg, Unk) (View Estring Review and Estring Label ), MENEST (.3 Mg, Unk) (View Menest Review and Menest Label ), FEMRING (Unk, Unk) (View Femring Review and Femring Label ), ESTRATEST (.625 Mg, Unk) (View Estratest Review and Estratest Label ), PROSOM (View Prosom Review and Prosom Label ). Patient was hospitalized.

6044927-6 | Nipple Exudate Bloody, Nipple Pain
on Jan 16, 2009 Female patient from UNITED STATES , 69 years of age, weighting 115.0 lb, was diagnosed with vulvovaginal discomfort and was treated with Vagifem (View Usage). Patient had the following side effects: nipple exudate bloody, nipple pain. Vagifem dosage: Oct 2008 2 Weeks Dec 2008 1 1/2 Weeks.

6038933-5 | Product Quality Issue, Vaginal Erythema, Vaginal Mucosal Blistering
on Jan 14, 2009 Female patient from UNITED STATES , 56 years of age, was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: product quality issue, vaginal erythema, vaginal mucosal blistering. Vagifem dosage: 1 Suppository Two Times-weekly Vag.

6022427-7 | Vaginal Inflammation, Vulvovaginal Pain
Patient was taking Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: vaginal inflammation, vulvovaginal pain on Dec 21, 2008 from UNITED STATES Additional patient health information: Female patient , 39 years of age, weighting 140.0 lb, was diagnosed with menstrual disorder, vulvovaginal discomfort and. Vagifem dosage: 2 X A Week 1x Vag. Patient was hospitalized.

5972647-2 | Arthritis, Fatigue, Pulmonary Embolism
Adverse event was reported on Nov 18, 2008 by a Female patient taking Vagifem (View Usage) (Dosage: Unk) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: arthritis (What is arthritis?), fatigue, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5951711-8 | Breast Cancer
on Oct 31, 2008 Female patient from UNITED STATES , 52 years of age, was treated with Vagifem (View Usage). After Vagifem was administered, patient had the following side effects: breast cancer (What is breast cancer?). Vagifem dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTRATEST (View Estratest Review and Estratest Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ).

5948091-0 | Breast Cancer Stage Ii
on Oct 31, 2008 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with vulvovaginal dryness, menopause (What is menopause?), menstruation irregular, depression (What is depression?), breast cancer stage ii and was treated with Vagifem (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer stage ii. Vagifem dosage: . During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ), ORTHO TRI CYCLEN (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ), PREMARIN (42.5 Mg, Cream) (View Premarin Review and Premarin Label ), ESTRING (2 Mg) (View Estring Review and Estring Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5948089-2 | Breast Cancer
Patient was taking Vagifem (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Oct 31, 2008 from UNITED STATES Additional patient health information: Female patient , 52 years of age, . Vagifem dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTRACE (View Estrace Review and Estrace Label ), ESTRATEST (View Estratest Review and Estratest Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ).